High Tide Inc (HITI)
TSX Venture Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 3.710 |
|---|---|
| 52-week range | 2.860 – 4.890 |
| Return, 1 month / 3 months | −4.4% / +22.0% |
| Return, 1 year / 3 years | −14.7% / +80.1% |
| Trend | Uptrend |
| RSI (14) | 50 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -38.4% |
| Average daily value traded | 0.29M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
High Tide Inc is a Canadian cannabis company based in Calgary, Alberta. It runs retail cannabis stores under the Canna Cabana banner, serving adult recreational customers in communities across the country. Alongside its stores, the company operates online platforms that offer cannabis accessories and related consumption products, reaching customers through e-commerce as well as physical shops. Its business combines bricks-and-mortar cannabis retail with online sales of smoking and vaping accessories, giving it a presence in both the retail and online sides of the cannabis consumer market.
High Tide Inc trades under the code HITI on the TSX Venture Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
High Tide Inc (HITI) trades on the TSX Venture Exchange in Canada. It last closed at CAD 3.710 on 22 October 2026.
Its price-based Market X-Ray is 83 out of 100 (a strong price profile), ranking 54 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.7% and over the last three months it rose 22.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 10.2% | ||
| From 52-week high | -20.4% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 22.0% | ||
| 6-month return | 4.8% | ||
| 12-month return, skipping the last month | -10.8% | ||
| Stability (higher is calmer) | 86 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.4% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 0.29M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.5% |
|---|---|
| 1 month | −4.4% |
| 3 months | +22.0% |
| 6 months | +4.8% |
| 1 year | −14.7% |
| 3 years | +80.1% |
| 5 years | −46.6% |
Signals
| 50-day / 200-day average | 3.621 / 3.367 |
|---|---|
| Golden / death cross (60 days) | Golden, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.129 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.